A HEPA purifier is the first thing many parents buy for a child’s asthma. In a year-long randomized trial, the machines measurably cleaned the air — and the main asthma-control score stayed flat. What that does and doesn’t mean is worth reading carefully.
It’s an appealing story: plug in a box, filter the air, breathe easier. The better evidence says a purifier is a tool for one specific problem, and it helps only when that problem is actually yours. A recent trial in children with poorly controlled asthma shows exactly where the benefit is real and where the marketing runs ahead of the data.
What the trial did
Rebecca Drieling, Catherine Karr and colleagues at the University of Washington ran the Home Air in Agriculture Pediatric Intervention (HAPI) trial, published in Environmental Health in 2022. They enrolled 75 rural farmworker children, ages 6 to 12, all with poorly controlled asthma and all in non-smoking homes in Washington’s Yakima Valley. Every family received the same community-health-worker asthma education. Children were then randomly assigned to that education alone, or to the education plus two portable HEPA air cleaners — one in the sleeping area, one in the living room — run for a year. The team tracked the Asthma Control Test (ACT) score, recent symptom days, and unplanned clinic or emergency visits.
What they found
The machines worked as machines. HEPA cleaners cut the geometric-mean fine-particle concentration in the child’s sleeping area by about 60% and in the living room by about 42% compared with education alone. That is a real, measured drop in the pollutant.
The health headline is where it gets honest. The pre-specified primary outcome — change in the ACT control score — was no better with HEPA than with education alone (difference in mean change 10%, 95% CI −12% to 39%). The confidence interval crosses zero, so the primary result was not statistically significant.
Particles down ~60%, primary asthma-control score unchanged (Drieling et al., 2022).
The clearer signal was in the secondary analyses. The share of children in the “poorly controlled” range (an ACT score of 19 or lower) fell from 15.8% to 8.3% with HEPA, versus 32.4% to 20.0% in the control group (IRR 0.45, 95% CI 0.21–0.97). Over the year, children with HEPA cleaners had a 57% lower risk of ever being poorly controlled (IRR 0.43, 0.21–0.89), a 28% lower risk of ever reporting symptom days (IRR 0.71, 0.52–0.98), and a 65% lower risk of ever needing an unplanned asthma visit (IRR 0.35, 0.13–0.94). Among the 67 children already on a controller medication, the drop in recent symptoms reached significance on the main analysis too (IRR 0.53, 0.29–0.98).
65% lower risk of an urgent visit — in secondary analysis, children with HEPA cleaners were far less likely to ever need unplanned asthma care over the study year (Drieling et al., 2022).
Why cleaner air didn’t move the headline number
Two reasons, and the second is the useful one. The study was small — 75 children, 70 finishing — and powered to detect a fairly large shift in the raw ACT score, so a real but modest benefit could hide inside a wide confidence interval. And particles were only a modest part of these homes to begin with: baseline indoor fine-particle levels averaged about 11–12 µg/m³, near the U.S. EPA’s annual outdoor standard at the time (12 µg/m³), not the heavy load of a home with a smoker. A cleaner can only remove what’s there. Take out most of the particles and you help most where particles were driving the symptoms — which is why the benefit landed on the worst-day measures rather than the everyday score.
A note on certainty: this trial was unblinded — families knew whether they’d received a machine — and most outcomes were parent-reported, both of which can nudge results. The primary analyses did not reach significance, so the encouraging numbers are secondary and should be read as suggestive, not settled. It’s one community, 75 children, and adherence was self-reported (81% said they rarely switched the units off). The authors state plainly that larger, blinded trials are needed. What survives all of that: the cleaners measurably lowered particles, and the children with them were less likely to hit the worst asthma days.
What gets lost in the air-purifier aisle
Purifiers are marketed as an asthma fix, full stop. The evidence is narrower. Across the better trials, portable HEPA cleaners reliably lower airborne particles, and they help asthma most in homes where particles — tobacco or wood smoke, traffic, agricultural dust — are the real trigger. The U.S. EPA makes the same point: air cleaners can reduce particles, but they do not remove gaseous pollutants, and they are no substitute for controlling the source. A HEPA unit does nothing for a damp wall growing mold, and little for a gas the filter can’t catch. It treats one input, and only if that input is your problem.
What this means for your home
Find the driver before you buy the box. If a child’s asthma flares indoors, work out what’s actually in the air — moisture and mold, combustion from a gas stove or wood heat, tobacco smoke, or fine particles from outside — and fix the source first: dry the leak, vent the stove, clear the smoke. Where fine particles remain part of the picture, a true HEPA cleaner sized for the room and run continuously in the bedroom is a reasonable add-on to good asthma care and trigger control — not a replacement for either. The bottom line from this trial is quiet but clear: the cleaner did its job on particles, the primary asthma score didn’t move, and the real benefit landed on the worst-day risks, mostly where particles were the trigger.
Not sure what’s driving the air? Measure it first. illumenair helps Portland and Vancouver homeowners find what’s actually driving their indoor air — moisture, mold, combustion, or particles — and figure out what to do next.
971-363-5626 · info@illumenair.com · illumenair.com
Sources: Drieling RL, Karr CJ, et al. “Randomized trial of a portable HEPA air cleaner intervention to reduce asthma morbidity among Latino children in an agricultural community.” Environmental Health 2022;21:1. · Riederer AM, Krenz JE, Tchong-French MI, et al. “Effectiveness of portable HEPA air cleaners on reducing indoor PM2.5 and NH3 in an agricultural cohort of children with asthma.” Indoor Air 2021;31(2):454–466. · U.S. Environmental Protection Agency, “Guide to Air Cleaners in the Home.”